Results 111 to 120 of about 6,264 (124)
Some of the next articles are maybe not open access.

In silico evaluation of the compounds of the ayurvedic drug, AYUSH-64, for the action against the SARS-CoV-2 main protease

Journal of Ayurveda and Integrative Medicine, 2022
Manohar Gundeti   +2 more
exaly  

Network pharmacology of AYUSH recommended immune-boosting medicinal plants against COVID-19

Journal of Ayurveda and Integrative Medicine, 2022
Shailendra Gurav   +2 more
exaly  

Impact of AYUSH 64 as an adjunctive to standard of care in mild COVID 19 - An open-label randomized controlled pilot study

Journal of Ayurveda and Integrative Medicine, 2022
Kalpesh Panara   +2 more
exaly  

AYUSH (Indian System of Medicines) Therapeutics for COVID-19: A Living Systematic Review and Meta-Analysis (First Update)

Journal of Integrative and Complementary Medicine, 2023
Kalpesh Panara, Anup Thakar
exaly  

AYUSH 64, a polyherbal Ayurvedic formulation in Influenza-like illness - Results of a pilot study

Journal of Ayurveda and Integrative Medicine, 2022
Shruti Khanduri   +2 more
exaly  

Immunity against COVID-19: Potential role of Ayush Kwath

Journal of Ayurveda and Integrative Medicine, 2022
Shankar Gautam   +2 more
exaly  

Home - About - Disclaimer - Privacy